127 related articles for article (PubMed ID: 11907466)
1. The promise of microarray technology in melanoma care.
Kim CJ; Reintgen DS; Yeatman TJ
Cancer Control; 2002; 9(1):49-53. PubMed ID: 11907466
[TBL] [Abstract][Full Text] [Related]
2. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin.
Cheng SL; Liu RH; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
J Biomed Sci; 2007 Jan; 14(1):87-105. PubMed ID: 17103032
[TBL] [Abstract][Full Text] [Related]
5. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
[TBL] [Abstract][Full Text] [Related]
6. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
7. Melanoma progression, gene expression and DNA microarrays.
Hoek KS
G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
9. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
13. Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma.
Trent JM; Bittner M; Zhang J; Wiltshire R; Ray M; Su Y; Gracia E; Meltzer P; De Risi J; Penland L; Brown P
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():33-40. PubMed ID: 9020934
[TBL] [Abstract][Full Text] [Related]
14. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
Heimerl S; Bosserhoff AK; Langmann T; Ecker J; Schmitz G
Melanoma Res; 2007 Oct; 17(5):265-73. PubMed ID: 17885581
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
Cheng SL; Huang Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
Biol Pharm Bull; 2006 Apr; 29(4):655-69. PubMed ID: 16595896
[TBL] [Abstract][Full Text] [Related]
16. Genomic investigations of posterior uveal melanoma.
Hovland PG; Trempe C
Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
[TBL] [Abstract][Full Text] [Related]
17. Predicting clinical outcome through molecular profiling in stage III melanoma.
John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS
Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035
[TBL] [Abstract][Full Text] [Related]
18. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
[TBL] [Abstract][Full Text] [Related]
19. DNA microarray technology and its applications in dermatology.
Kunz M; Ibrahim SM; Koczan D; Scheid S; Thiesen HJ; Gross G
Exp Dermatol; 2004 Oct; 13(10):593-606. PubMed ID: 15447719
[TBL] [Abstract][Full Text] [Related]
20. [Gene expression profiles in the diagnosis and prognosis of cancer].
Kopper L; Tímár J
Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]